Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Stock Information | RedChip

Perspective Therapeutics Inc. (NYSE AMERICAN: CATX)


$3.5100
-0.0200 ( -0.23% ) 0.5K

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

Market Data


Open


$3.5100

Previous close


$3.5300

Volume


0.5K

Market cap


$238.58M

Day range


$3.3600 - $3.5180

52 week range


$2.7000 - $19.0500

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 78 Nov 12, 2024
8-k 8K-related 13 Nov 12, 2024
8-k 8K-related 15 Oct 11, 2024
8-k 8K-related 16 Sep 20, 2024
8-k 8K-related 13 Sep 05, 2024
8-k 8K-related 11 Aug 30, 2024
8-k 8K-related 11 Aug 19, 2024
8-k 8K-related 14 Aug 13, 2024
10-q Quarterly Reports 80 Aug 13, 2024
8-k 8K-related 123 Aug 13, 2024

Latest News